PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW132585View Pathway |
Celiprolol Drug MetabolismHomo sapiens
Celiprolol is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Celiprolol passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 22:30 Last Updated: September 21, 2023 at 22:30 |
PW145596View Pathway |
drug action
Celiprolol Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:10 Last Updated: October 07, 2023 at 16:10 |
PW122302View Pathway |
cellobiose biosynthesisBacillus velezensis MRC5958
The cellulase enzyme system consists of cellobiohydrolase, endoglucanase, and beta-glucosidase and has been extensively studied with respect to its biosynthesis, properties, mode of action, application, and, most recently, secretion mechanisms. A knowledge of the factors governing the biosynthesis and secretion of these enzymes at the molecular level will be useful in maximizing enzyme productivity in extracellular fluid.
|
Creator: Ng Ngashangva Created On: November 22, 2018 at 01:23 Last Updated: November 22, 2018 at 01:23 |
PW122295View Pathway |
Cellular MetabolismEscherichia coli
|
Creator: Guest: Anonymous Created On: November 15, 2018 at 11:24 Last Updated: November 15, 2018 at 11:24 |
PW132391View Pathway |
Cenobamate Drug MetabolismHomo sapiens
Cenobamate is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Cenobamate passes through the liver and is then excreted from the body mainly through the kidney.
|
Creator: Ray Kruger Created On: September 21, 2023 at 21:25 Last Updated: September 21, 2023 at 21:25 |
PW145655View Pathway |
drug action
Cenobamate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:19 Last Updated: October 07, 2023 at 16:19 |
PW123987View Pathway |
Central Carbon Metabolism 1594740445actinobacillus succinogenes 130Z
|
Creator: Guest: Anonymous Created On: July 14, 2020 at 09:27 Last Updated: July 14, 2020 at 09:27 |
PW122345View Pathway |
Central Carbon Pathway and offshootsHomo sapiens
Metabolic Biochemistry
|
Creator: Talia Lichtenberg Created On: February 16, 2019 at 20:13 Last Updated: February 16, 2019 at 20:13 |
PW126863View Pathway |
drug action
Cephalexin Action Pathway (New)Streptococcus pneumoniae (strain ATCC BAA-255 / R6)
Cephalexin is a first-generation cephalosporin used to treat certain susceptible bacterial infections. These infections include respiratory tract infections, otitis media, skin and skin structure infections, bone infections, and genitourinary tract infections.
Cephalexin is administered orally as either 250 mg or 500 mg capsules. These capsules can be given 1 to 4 times daily, usually administered for seven days.
Cephalexin inhibits penicillin binding proteins. Penicillin binding proteins are responsible for glycosyltransferase and transpeptidase reactions that lead to cross-linking of D-alanine and D-aspartic acid in bacterial cell walls. Inhibition of this protein leads to upregulation of autolytic enzymes and inhibition of cell wall synthesis. Cephalexin eventually leads to cell death.
Side effects of taking cephalexin include abdominal pain, diarrhea, dyspepsia, gastritis, nausea, vomiting, erythema multiforme, genital pruritus, vaginitis, vaginal discharge, candidiasis, thrombocytopenia, neutropenia, eosinophilia, arthralgia, arthropathy, and arthritis.
|
Creator: Karxena Harford Created On: April 22, 2022 at 01:38 Last Updated: April 22, 2022 at 01:38 |
PW144684View Pathway |
drug action
Cephalexin Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:13 Last Updated: October 07, 2023 at 14:13 |